Fifth Third Bancorp Purchases 41,446 Shares of Agilent Technologies, Inc. $A

Fifth Third Bancorp boosted its position in Agilent Technologies, Inc. (NYSE:A) by 185.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 63,847 shares of the medical research company’s stock after purchasing an additional 41,446 shares during the period. Fifth Third Bancorp’s holdings in Agilent Technologies were worth $7,277,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after acquiring an additional 1,713,216 shares during the period. State Street Corp lifted its stake in shares of Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after purchasing an additional 241,029 shares during the period. Geode Capital Management LLC lifted its stake in shares of Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after purchasing an additional 25,139 shares during the period. Morgan Stanley boosted its position in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Agilent Technologies during the 4th quarter valued at about $549,158,000.

Analysts Set New Price Targets

A number of brokerages have weighed in on A. Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. Robert W. Baird increased their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. HSBC reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $136.14 on Friday. The business has a 50-day simple moving average of $127.17 and a 200 day simple moving average of $125.58. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $38.45 billion, a price-to-earnings ratio of 27.34, a PEG ratio of 2.40 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the company earned $1.31 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.